Enterprise Biomarker Services

Opportunities for optimizing clinical development strategies

The use of biomarkers in clinical development programs is a growing requirement for many disease areas. With this, there are new opportunities to integrate biological markers into your clinical development plan including:

Biomarker development - Identifying the right mechanism of action or specific disease indication
Biomarker assay testing - Choosing the right platform for developing a robust assay
Aligning development plans for successful co-development of drug and diagnostic

Identification of predictive biomarkers is essential for anti-cancer drug development. IQVIA Laboratories biomarker laboratory services help drug developers generate a biomarker identification strategy to help drive clinical and commercial success of a drug.

Biomarker expertise

Having helped develop some of the industry’s most well-known biological markers for personalized medicine including BCR-Abl, ALK, BRAF, C-KIT, EGFR, KRAS, HER2, MET, and PD-L1, we have the experience to incorporate these tools across the drug development process:

Early clinical development

Our scientific experts and biomarker lab staff can help you develop translational design strategies to identify, develop assays, and screen multiple biomarkers in parallel, so the most relevant ones can be identified sooner and get you to proof of concept as early as possible.

Clinical biomarker services and development

With clinical and scientific experts spanning multiple major disease states, we can use biomarkers to help optimize your clinical trials. Our global teams include assay development experts working in the largest system of CAP-accredited central laboratories. Employing comprehensive genomic, molecular and protein-based platforms we can rapidly and seamlessly develop, test, transfer, and integrate biological markers.

Pre-launch and commercialization

We work with IQVIA Laboratories global experts in market access for drug/diagnostic combinations to develop robust product launch plans and commercial strategies.

Biomarker testing excellence

Our biomarker testing services and extensive capabilities and expertise to support identification and analysis including immunoassays, flow cytometry, genomic, liquid chromatography–mass spectrometry (LC/MS), as well as anatomic pathology and molecular pathology solutions.

Our world-renowned biomarker services scientific staff can help integrate biological markers across your development plan, from discovery, clinical development, and commercialization.

Download our brochure to view additional key disciplines and services to support your strategy.

Biomarker assay services for your success

IQVIA Laboratories has the breadth and depth of expertise, tools and capabilities to prepare and implement strategies to help drug developers effectively gain a competitive advantage – helping ensure your success in clinical trials, regulatory approvals and new product launches.

IQVIA Laboratories is your partner of choice for any program which requires biomarker identification, assay development, qualification and analysis to meet customer requirements.

Related Services

card-3212_Close-up shot of microscope with metal lens at laboratory

Anatomic Pathology Laboratory Services

Learn more

Bioanalytical Services

Learn more

card-3211_Scientist wearing safety glasses

ADME / DMPK Services

Learn more

card-3223_Nurse standing in a laboratory and taking test tubes with blood samples

Biomarker Services

Learn more

card-3233_Laboratory scientist working at lab with micropipette, and 96 well plate

Biotech Laboratory Solutions

Learn more

Website Featured_JPG-3842_Scientist working in the Laboratory

Central Laboratory Services

Learn more

Clinical Genomics Laboratory Services

Learn more

card-3254_team of doctors working with vaccine research

COVID-19 Clinical Trial Solutions

Learn more

card-3270_young woman scientist in laboratory working

Companion Diagnostics (CDx)

Learn more

card-3234_Liquid drop from pipette to test tube

Flow Cytometry Assay Development

Learn more

card-3216_Biochemistry expert scientific with eyeglasses

Translational Science and Innovations Laboratory Services (TSAIL)

Learn more

card-3276_A medical scientist is preparing a pathological specimen for diagnosis

Vaccine Laboratory Services

Learn more

Related Insights

Insight Brief

Managing Informed Consent Samples from Clinical Trials

A set of best practices for the definition, tracking and management of allowable use attributes associated with samples collected in protocol based clinical trials